Asian Growth Stocks With High Insider Ownership For October 2026
As the Asian markets navigate through a period of heightened uncertainty driven by global inflation pressures and AI investment concerns, investors are increasingly seeking opportunities in growth stocks with solid foundations. In this environment, companies with high insider ownership can offer a sense of stability and alignment of interests, making them attractive options for those looking to capitalize on potential growth while mitigating risks associated with broader market volatility.
Top 10 Growth Companies With High Insider Ownership In Asia
| Name | Insider Ownership | Earnings Growth |
| Shanghai Skychem Technology (SHSE:688603) | 31.8% | 67.7% |
| Seojin SystemLtd (KOSDAQ:A178320) | 18% | 106.6% |
| SEERS (KOSDAQ:A458870) | 33.8% | 37.8% |
| Meitu (SEHK:1357) | 23.1% | 26.7% |
| Meiko Electronics (TSE:6787) | 19.2% | 34% |
| KCTech (KOSE:A281820) | 20.6% | 31.6% |
| HUMAN MADE (TSE:456A) | 29.1% | 28.7% |
| Guangdong Shenling Environmental Systems (SZSE:301018) | 36.7% | 65.4% |
| Great Microwave Technology (SHSE:688270) | 21.1% | 95.2% |
| Beijing Luzhu Biotechnology (SEHK:2480) | 39.7% | 84.3% |
Let's review some notable picks from our screened stocks.
OKins ElectronicsLtd (KOSDAQ:A080580)
Simply Wall St Growth Rating: ★★★★★★
Overview: Okins Electronics Co., Ltd. specializes in the manufacturing and sale of semiconductor inspection sockets, with a market cap of ₩611.64 billion.
Operations: The company's revenue is primarily derived from the manufacturing of semiconductor inspection sockets and related products, totaling ₩97.98 billion, alongside its test service business which contributes ₩8.02 billion.
Insider Ownership: 16%
OKins Electronics Ltd. is experiencing robust growth, with earnings projected to rise 52.2% annually and revenue expected to increase by 46% per year, both outpacing the KR market averages. The company became profitable this year and boasts high-quality non-cash earnings, although its share price has been highly volatile recently. Notably, OKins was added to the S&P Global BMI Index in September 2026, potentially enhancing its visibility among investors.
- Dive into the specifics of OKins ElectronicsLtd here with our thorough growth forecast report.
- Our valuation report here indicates OKins ElectronicsLtd may be overvalued.
Chery Automobile (SEHK:9973)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Chery Automobile Co., Ltd. engages in the design, development, manufacture, and sale of passenger vehicles and automotive parts both in China and internationally, with a market capitalization of approximately HK$141.15 billion.
Operations: The company generates revenue from its auto manufacturing segment, which amounted to CN¥301.97 billion.
Insider Ownership: 15.9%
Chery Automobile is positioned for growth with a focus on expanding its presence in the EU, aiming to operate in 27 markets by 2027. The company is trading at a significant discount to fair value, with earnings forecasted to grow faster than the Hong Kong market average. Its recent product launches, such as FREELANDER 8 and increased R&D investment, highlight its commitment to innovation and market expansion. Despite high insider ownership supporting confidence in leadership, no substantial recent insider trading activity has been reported.
- Delve into the full analysis future growth report here for a deeper understanding of Chery Automobile.
- Our valuation report here indicates Chery Automobile may be undervalued.
Guangdong Zhongsheng Pharmaceutical (SZSE:002317)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Guangdong Zhongsheng Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and production of medical products, with a market cap of CN¥22.51 billion.
Operations: The company's revenue is primarily derived from Pharmaceutical Manufacturing, contributing CN¥2.12 billion, and Medicine Trade, which accounts for CN¥90.35 million.
Insider Ownership: 27.5%
Guangdong Zhongsheng Pharmaceutical demonstrates growth potential with earnings forecasted to grow significantly faster than the Chinese market, despite recent declines in sales and net income. The stock trades at a substantial discount to its estimated fair value, indicating potential undervaluation. Although revenue growth is slower than desired, it still surpasses the market average. High insider ownership suggests confidence in leadership, though no recent insider trading activity has been noted.
- Get an in-depth perspective on Guangdong Zhongsheng Pharmaceutical's performance by reading our analyst estimates report here.
- Our comprehensive valuation report raises the possibility that Guangdong Zhongsheng Pharmaceutical is priced higher than what may be justified by its financials.
Taking Advantage
- Access the full spectrum of 510 Fast Growing Asian Companies With High Insider Ownership by clicking on this link.
- Searching for a Fresh Perspective? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com